Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Elder

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|November 18, 2015
TSLP production by dendritic cells is modulated by IL-1β and components of the endoplasmic reticulum stress responseMatthew J Elder, Steven J Webster, David L Williams, et al.
Frontiers in Immunology|July 25, 2017
β-Glucan Size Controls Dectin-1-Mediated Immune Responses in Human Dendritic Cells by Regulating IL-1β ProductionMatthew J Elder, Steve J Webster, Ronnie Chee, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2020
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitroShannon Burke, Amy Shergold, Matthew J Elder, et al.
Frontiers in Immunology|March 20, 2023
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized miceAlba Matas-Céspedes, Jean-Martin Lapointe, Matthew J Elder, et al.
Microbes and Infection|March 30, 2016
IRE1α mediates PKR activation in response to Chlamydia trachomatis infectionSteve J Webster, Lou Ellis, Louise M O'Brien, et al.
Plos Pathogens|June 2, 2017
Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infectionSteve J Webster, Sven Brode, Lou Ellis, et al.
Frontiers in Immunology|May 30, 2019
Dendritic Cell-Derived TSLP Negatively Regulates HIF-1α and IL-1β During Dectin-1 SignalingMatthew J Elder, Steve J Webster, Timothy J Fitzmaurice, et al.
Journal for Immunotherapy of Cancer|September 13, 2019
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapiesStefanie R Mullins, John P Vasilakos, Katharina Deschler, et al.
Gut|February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's diseaseJames B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Cancer Discovery|January 9, 2021
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1<sup>+</sup> Activated T CellsSimon J Dovedi, Matthew J Elder, Chunning Yang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|November 18, 2015
TSLP production by dendritic cells is modulated by IL-1β and components of the endoplasmic reticulum stress responseMatthew J Elder, Steven J Webster, David L Williams, et al.
Frontiers in Immunology|July 25, 2017
β-Glucan Size Controls Dectin-1-Mediated Immune Responses in Human Dendritic Cells by Regulating IL-1β ProductionMatthew J Elder, Steve J Webster, Ronnie Chee, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2020
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitroShannon Burke, Amy Shergold, Matthew J Elder, et al.
Frontiers in Immunology|March 20, 2023
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized miceAlba Matas-Céspedes, Jean-Martin Lapointe, Matthew J Elder, et al.
Microbes and Infection|March 30, 2016
IRE1α mediates PKR activation in response to Chlamydia trachomatis infectionSteve J Webster, Lou Ellis, Louise M O'Brien, et al.
Plos Pathogens|June 2, 2017
Detection of a microbial metabolite by STING regulates inflammasome activation in response to Chlamydia trachomatis infectionSteve J Webster, Sven Brode, Lou Ellis, et al.
Frontiers in Immunology|May 30, 2019
Dendritic Cell-Derived TSLP Negatively Regulates HIF-1α and IL-1β During Dectin-1 SignalingMatthew J Elder, Steve J Webster, Timothy J Fitzmaurice, et al.
Journal for Immunotherapy of Cancer|September 13, 2019
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapiesStefanie R Mullins, John P Vasilakos, Katharina Deschler, et al.
Gut|February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's diseaseJames B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Cancer Discovery|January 9, 2021
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1<sup>+</sup> Activated T CellsSimon J Dovedi, Matthew J Elder, Chunning Yang, et al.
Pageof 1